Article
A novel method for predicting Lp(a) levels from routine outpatient genomic testing identifies those at risk of cardiovascular disease across a diverse cohort
2024-11-04
Abstract excerpt
<h4>Background</h4> Lipoprotein(a) (Lp(a)) levels are a largely genetically determined and often an unmeasured predictor of future Atherosclerotic Cardiovascular Disease (ASCVD). With the increased use of exome sequencing in the clinical setting, there is opportunity to identify patients who have a high chance of having elevated Lp(a) and are therefore at risk of ASCVD. However, accurate genetic predictors of Lp(a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f93a1c4c-ef67-5a19-8195-f03c7ae48ae0
- DOI
- 10.1101/2024.11.01.24316526
